De Man, Kathia http://orcid.org/0000-0002-7062-6389
Piron, Sarah
Van Laeken, Nick
Delrue, Louke
Fonteyne, Valérie
Lumen, Nicolaas
Van den Broeck, Bliede
Kersemans, Ken
Ost, Piet
Schelfhout, Vanessa
Funding for this research was provided by:
FWO (T001517)
Article History
Received: 5 January 2022
Revised: 11 March 2022
Accepted: 21 March 2022
First Online: 11 April 2022
Declarations
:
: Prof. Dr. P. Ost has received research grants from Bayer and Varian and has consulted for Janssen, Bayer, Curium, Novartis, and Ferring. Prof. Dr. N. Lumen has consulted for Bayer, Astra Zeneca, Ipsen, Janssen, and Astellas. The other authors declare that they have no conflict of interests.